Punjab Chief Minister Chaudhry Pervaiz Elahi has approved the installation of Cyberknife Technology in Jinnah Hospital Lahore and Nishtar Hospital Multan.
Punjab Chief Minister Chaudhry Pervaiz Elahi has approved the installation of Cyberknife Technology in Jinnah Hospital Lahore and Nishtar Hospital Multan.
As per details, A high-level meeting was held under the chairmanship of CM Elahi in which it was decided to introduce CyberKnife technology in Jinnah Hospital Lahore and Nishtar Hospital Multan.
While addressing the meeting, CM Elahi said that with CyberKnife Technology complex diseases like Cancer and other diseases will be treated free of cost. Pervaiz Elahi further said that doctors will also be trained on how to use CyberKnife Technology.
Radiosurgery minimizes radiation exposure to healthy tissue surrounding the tumor. Compared to other radiosurgical treatments, the CyberKnife offers several advantages to patients, including rapid relief from pain and other symptoms.
Treatments are performed on an outpatient basis, with each treatment lasting between 30 and 90 minutes. The number of treatments vary depending on the tumor size, location and shape, but typically only one to five daily sessions are required.
The CyberKnife allows patients to lie comfortably on the procedure table without anesthesia while the robotic arm moves, without touching them, to treat all areas of the tumor. Recovery is often immediate, given its low risk of complications and damage to healthy tissue.
In a clinical study of 333 patients using the CyberKnife System to treat tumor metastases to the brain, more than 85 percent of evaluable patients achieved local tumor control at two years post treatment2. That is, the tumor either decreased in size or stopped growing.
Cyberknife Is More Accurate Than Traditional Radiation Therapy. Because it’s able to target diseased tissue, Cyberknife SBRT is much more accurate than traditional radiation therapy. SBRT can deliver radiation to a margin of one to five millimeters surrounding a tumor.
Most patients with brain metastases from extracranial primary tumors such as lung or breast cancer receive palliative treatment approaches, because the common pattern of polymetastatic spread may cause compromised performance status (PS) and eventually also limited survival, often in the range of 3–9 months.